Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy-Reference-Cited by-同舟云学术

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy

Published:2019-11-15 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Veselska Renata,Jezova Marta,Kyr Michal,Mazanek Pavel,Chlapek Petr,Dobrotkova Viera,Sterba Jaroslav

Funder

Ministerstvo Zdravotnictví Ceské Republiky

Ministerstvo Školství, Mládeže a Telovýchovy

Masarykova Univerzita

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference43 articles.

1. Children's Oncology Group's 2013 blueprint for research: neuroblastoma;Park;Pediatr Blood Cancer,2013

2. Neuroblastoma: paradigm for precision medicine;Irwin;Pediatr Clin North Am,2015

3. Neuroblastoma origin and therapeutic targets for immunotherapy;Kholodenko;J Immunol Res,2018

4. Neuroblastoma;Nakagawara;Jpn J Clin Oncol,2018

5. Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature;Kushner;Cancer,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

2. PBX1: a TALE of two seasons—key roles during development and in cancer;Frontiers in Cell and Developmental Biology;2024-02-09

3. Thymic lymphoma detection in RORγ knockout mice using 5-hydroxymethylcytosine profiling of circulating cell-free DNA;Toxicology and Applied Pharmacology;2023-08

4. Comprehensive overview of the role of PBX1 in mammalian kidneys;Frontiers in Molecular Biosciences;2023-03-17

5. PBX1: a key character of the hallmarks of cancer;Journal of Molecular Medicine;2021-09-16